Session proposals

Each year the European Respiratory Society (ERS) welcomes your session proposals for the ERS International Congress, as these contributions help us to deliver a varied and engaging scientific and educational programme.

This section contains up-to-date information on all session proposal deadlines and priority topics for this year’s event.

Check the session types web page for details on what is included in the ERS congress programme.

Deadlines

EventCall openDeadlineSubmissions being accepted
ERS 202127 June, 20207 September, 2020Symposia
ERS 202115 December, 20207 March, 2021Hot topics
ERS 202229 June, 202110 September, 2021Symposia
ERS 202215 December, 2021TBC March, 2022Hot topics

Proposal tips

Check our tips for submitting a session proposal before sending your submission.

View session proposal tips

Priority topics for 2021

The chosen theme for the ERS International Congress 2021 programme is digital health, which will be covered extensively in a range of scientific and educational sessions.

In addition to digital health, the congress programme will also feature the latest advances in research and clinical practice from the following topics and professional specialities:

General pneumology

Areas covered will include:

  • overlapping lung disease.
  • digital health interventions for the management of respiratory patients.
  • adverse drug reactions and the lungs.
  • beyond COVID-19 – a 360-degree view from patients, professionals and public health on life after pandemics.
  • physiology and rehabilitation for COVID-19 patients.

Respiratory intensive care

Areas covered will include:

  • long-term nasal high flow therapy: in whom and how?
  • monitoring of noninvasive ventilation: what is necessary?
  • preparing for the next respiratory pandemic.
  • machine learning in respiratory critical care.
  • technical and ethical aspects of long-term home mechanical ventilation.

Basic and translational sciences

Areas covered will include:

  • deep phenotyping of emerging respiratory diseases using immunology, genetics and transcriptomics, and exploration of the potential longer-term implications of these diseases.
  • impacts of the micro-environment and cellular repair mechanisms on the early origins of chronic lung disease.
  • utilising data from single cell approaches to study existing and recently emerging lung diseases.
  • novel imaging technologies for the study of respiratory molecular cell biology and lung regeneration.
  • integrated data analysis, bioinformatics, digital biomarkers and systems medicine to further basic and translational lung science.
  • cellular, oxidative, hypoxic, nutrient, and ER stress signalling in pulmonary disease.

Sleep and breathing disorders and clinical physiology

Areas covered will include:

  • new technologies in obstructive sleep apnoea diagnosis and treatment.
  • obesity hypoventilation syndrome: new classification and treatment choice.
  • obstructive sleep apnoea: residual sleepiness, cognitive impairment and fatigue from identification to treatment.
  • sleep in respiratory diseases: from pathophysiology to clinical implications.
  • ABCD classification of obstructive sleep apnoea: does it really works?
  • telemedicine and its role in diagnosis, treatment and follow-up of sleep breathing disorders.

Airway diseases, asthma and COPD

Areas covered will include:

  • new drugs in asthma and COPD: biologics and bronchodilators.
  • precision medicine in asthma and COPD.
  • low-T2 inflammation; the new Everest?
  • pharmacology of lung immune responses: which pathways to target?
  • how should we treat asthma in 2021?

Epidemiology and environment

Areas covered will include:

  • do genetic and environmental factors alter long term recovery from severe COVID19?
  • COVID-19 and work: from historical to modern day workplace perspectives.
  • highlights on gender and respiratory health: implications for research, prevention and clinical management of respiratory diseases.
  • life and work post COVID-19.
  • what works to prevent the uptake of nicotine and tobacco by youth: using social media and e-health approaches?

Paediatrics

Areas covered will include:

  • chronic lung inflammation and infection in children.
  • management of wheeze from birth to adolescence.
  • new technologies for the management of children with respiratory diseases.
  • treatable traits in preschool wheeze.
  • antimicrobial resistance and lung infections in children.

Thoracic surgery and transplantation

Areas covered will include:

  • lung graft allocation and monitoring in the 21st century.
  • integrating innovation and new technology into thoracic surgery.
  • artificial intelligence and innovative techniques in the management of chest malignancies.
  • digital health surveillance in the thoracic surgery pathway.

Allied respiratory professionals

Areas covered will include:

  • sarcopenia in chronic respiratory disease: new definitions, assessment and treatment options.
  • psychosocial care in chronic lung disease: nursing issues in chronic lung care.
  • fatigue and pain in COPD and other chronic respiratory diseases.
  • standardisation and updates concerning pulmonary function testing and interpretation.
  • allied health treatment in COVID-19: ICU, inpatient [ward] and after hospital discharge.
  • safe spirometry in the in the COVID-19 area, from primary care to tertiary centre, from proven PCR negative to COVID-19 positive patients.
  • post COVID-19 rehabilitation: different profiles and different settings.
  • tele-rehabilitation in chronic respiratory disease and COVID-19 / using novel technologies to organise rehabilitation with video conferencing.
  • rehabilitation 4–6 weeks after COVID-19 infection: how to start the rehabilitation, increase and assess the training intervention and the long-term follow-up; when, how and by whom?

Respiratory infections

Areas covered will include:

  • new diagnostic approaches and treatment regimens in tuberculosis.
  • managing antibiotic resistance in respiratory infection: applying the guidelines.
  • late complications of COVID-19.
  • comparing two WHO Global Health Emergencies: tuberculosis and COVID-19.
  • respiratory infection control and evidence behind personal protective equipment.

Thoracic oncology

Areas covered will include:

  • advances in lung cancer sampling and molecular subtyping.
  • advances in multimodal therapies in stage III non-small-cell lung carcinoma.
  • advances in targeted therapy of driver addicted lung cancer.
  • artificial intelligence in diagnostics and therapy of (suspected) lung cancer?
  • pleural malignancies: rational diagnostics and evidence-based local and systemic therapies.

Interstitial lung diseases

Areas covered will include:

  • COVID-19 – translational medicine, pathobiology and immunology in collaboration with the molecular group.
  • the effect of comorbidities in COVID-19: interstitial lung diseases before and after recovery.
  • long-term follow-up of interstitial lung diseases after recovery and possible antifibrotic regimens.
  • genetics and interstitial lung diseases.
  • progressive fibrosing interstitial lung disease.

Pulmonary vascular diseases

Areas covered will include:

  • COVID-19 and pulmonary vessels: what have we learned?
  • optimal follow-up after acute pulmonary embolism and long-term complications after pulmonary embolism.
  • early diagnosis of pulmonary hypertension, in the context of connective tissue disease, genetic predisposition and liver disease.
  • how to manage situations in pulmonary hypertension: travel, oxygen therapy, surgery, pregnancy, atrial fibrillation, chest pain?
  • duration of anticoagulant thromboprophylaxis in different settings.

Clinical techniques, imaging and endoscopy

Areas covered will include:

  • interventional pulmonology: rotation of advanced techniques simulators.
  • from endosonography, cryo and valves to pleural management.
  • interventional bronchoscopy board: interdisciplinary discussion of endoscopic cases.
  • transthoracic ultrasound.
  • correctly classifying interstitial lung diseases.

The ERS Congress Programme Committee encourages you to develop sessions that includes faculty members of varying ages, backgrounds, specialties and gender. The congress theme should be reflected in session proposals as much as possible.

Topics last updated in June 2020.

Contact us

Do you have questions about the congress programme or session proposals?

Get in touch